Brief: China Resources Pharmaceutical Posts Qtrly Net Profit Of CR Boya Bio-Pharmaceutical RMB174.4 Million
April 25 (Reuters) - China Resources Boya Bio
pharmaceutical 300294.SZ :
* QTRLY NET PROFIT OF CR BOYA BIO-PHARMACEUTICAL RMB174.4
MILLION
VERSUS RMB106.9 MILLION
* QTRLY REVENUE RMB805.9 MLN VS RMB654.6 MLN FOR CR BOYA
BIO-PHARMACEUTICAL
Further company coverage: 300294.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million